Ars Technica · 1 min read

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

This is a summary aggregated from Ars Technica. Read the complete article on the original site:

Read full article at Ars Technica

More Health & Medical News